We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
10 Year Est. Return
AUM
$33.5M
AUM Growth
-$39.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 33.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOR
1
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$7.21M 21.51%
1,092,976
PBYI icon
2
Puma Biotechnology
PBYI
$398M
$4.1M 12.21%
1,256,411

Similar funds

Athyrium Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Athyrium Capital Management held 3 positions worth $33.5M, down 54% from $72.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. Athyrium Capital Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 26% a quarter earlier.

  • Athyrium Capital Management's ten largest holdings make up 100% of its $33.5M portfolio in Q2 2024.
  • Athyrium Capital Management opened 0 new positions and closed 0 in Q2 2024.
  • Athyrium Capital Management's portfolio value fell 54% quarter-over-quarter to $33.5M.

Based on Athyrium Capital Management's 13F filing for Q2 2024, filed 8 Aug 2024.